MTD Group completes the acquisition of Ypsomed’s pen needles and blood glucose monitoring systems and announces a significant investment plan for its European production facilities
Medical Technology and Devices (MTD) is pleased to announce the successful completion of the strategic acquisition of Ypsomed’s pen needles and blood glucose monitoring systems (BGM) business units, announced at…